Heart attacks have been the leading cause of death in the U.S. for a century. While most treatments for cardiac events target breaking down blood clots, Georgia Tech researchers have found a way to prevent blood clots from even forming. Dramatically, their drug is shown to completely knock out the formation of blood clots without increasing the risks of bleeds in vivo. This drug is both affordable and already widely available for other uses, meaning patients could experience these benefits sooner than waiting for a completely new drug to go Read More